Association Between a Functional Catechol O-Methyltransferase Gene Polymorphism and Schizophrenia: Meta-Analysis of Case-Control and Family-Based Studies
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: There is strong evidence for a genetic contribution to schizophrenia, but efforts to identify susceptibility genes have been largely unsuccessful because of the low power of individual studies. The authors' goal was to evaluate the collective evidence for an association between the Val158/108Met polymorphism of the catechol O-methyltransferase (COMT) gene and schizophrenia. METHOD: They performed separate meta-analyses of existing case-control and family-based association studies. RESULTS: Overall, case-control studies showed no indication of an association between either allele and schizophrenia, and family-based studies found modest evidence implicating the Val allele in schizophrenia risk. The pooled analyses of studies from diverse geographical regions may have obscured ethnic differences in patterns of genetic risk for schizophrenia. Stratification of the studies by ethnicity of the subjects yielded evidence for an association with the Val allele in case-control studies of European samples and, especially, in family-based studies of European samples. Case-control and family-based studies of Asian samples produced mixed results and, overall, little evidence for association. CONCLUSIONS: The results of the two types of association studies diverged somewhat, but the evidence from the family-based studies, although based on fewer reports, may be more accurate. The Val allele may be a small but reliable risk factor for schizophrenia for people of European ancestry, but the influence of this polymorphism on risk in Asian populations remains unclear. These results call for more family-based studies to confirm the association between COMT and schizophrenia in European samples and to clarify its contribution to risk in Asian samples. They also suggest that case-control studies should use methods of genomic control to avoid being confounded by population stratification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
WOOLF, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,723
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Lotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melen, K., Julkunen, I., & Taskinen, J. (1995) · Biochemistry · doi:10.1021/bi00013a008 · Cited by 1,167
Schizophrenia genesis: the origins of madness
(1991) · Choice Reviews Online · doi:10.5860/choice.28-6500 · Cited by 832
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811 · cited 2×
“However, a meta-analysis of genome-wide linkage scans (17) identified chromosome 22q as one of three loci (along with chromosomes 8p and 13q) that had the highest likelihood of harboring schizophrenia-risk genes, which highlights the promise of COMT as a candidate gene for this disorder.”
BackgroundKety, S. S., Rosenthal, D., Wender, P. H., & Schulsinger, F. (1968) · Journal of Psychiatric Research · doi:10.1016/0022-3956(68)90026-5 · Cited by 704
Publication Bias and Dissemination of Clinical Research
Begg, C. B., & Berlin, J. A. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.107 · Cited by 440
Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles
Palmatier, M. A., Kang, A. M., & Kidd, K. K. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00098-0 · Cited by 381
Cited by
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Diatchenko, L., Slade, G. D., Nackley, A. G., Bhalang, K., Sigurdsson, A., Belfer, I., Goldman, D., Xu, K., Shabalina, S. A., Shagin, D., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi013 · Cited by 1,280
Bilder, R. M., Volavka, J., Lachman, H. M., & Grace, A. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300542 · Cited by 769
“…a role in discrepancies between studies and particularly in the divergent results from family-based and case–control studies; specifically, family-based studies are biased to include participants with higher levels of social support and involvement, or less severe pathology (Glatt et al, 2003).”
BackgroundResultCatechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond
Tunbridge, E. M., Harrison, P. J., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.024 · Cited by 685
PHASE II DRUG METABOLIZING ENZYMES
Jancova, P., Anzenbacher, P., & Anzenbacherova, E. (2010) · Biomedical Papers · doi:10.5507/bp.2010.017 · Cited by 603
The genetics of schizophrenia and bipolar disorder: dissecting psychosis
Craddock, N., O’Donovan, M. C., & Owen, M. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030718 · Cited by 574
Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures
Turetsky, B. I., Calkins, M. E., Light, G. A., Olincy, A., Radant, A. D., & Swerdlow, N. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl060 · Cited by 567
Genes for Schizophrenia and Bipolar Disorder? Implications for Psychiatric Nosology
Craddock, N. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj033 · Cited by 496
No Gene Is an Island: The Flip-Flop Phenomenon
Lin, P.-I., Vance, J. M., Pericak-Vance, M. A., & Martin, E. R. (2007) · The American Journal of Human Genetics · doi:10.1086/512133 · Cited by 465
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Abdolmaleky, H. M., Cheng, K.-H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl253 · Cited by 462
“The hyperactive Val allele of the Val158Met polymorphism was linked to schizophrenia and bipolar disorder (25,26).”
BackgroundSelf-citationBraff, D. L., Freedman, R., Schork, N. J., & Gottesman, I. I. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl049 · Cited by 455
Catechol- O -methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli
Diatchenko, L., Nackley, A. G., Slade, G. D., Bhalang, K., Belfer, I., Max, M. B., Goldman, D., & Maixner, W. (2006) · Pain · doi:10.1016/j.pain.2006.05.024 · Cited by 372
Impact of complex genetic variation in COMT on human brain function
Meyer-Lindenberg, A., Nichols, T., Callicott, J. H., Ding, J., Kolachana, B., Buckholtz, J., Mattay, V. S., Egan, M., & Weinberger, D. R. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001860 · Cited by 319
Harrison, P. J., & Tunbridge, E. M. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301543 · Cited by 308
Gatt, J. M., Burton, K. L. O., Williams, L. M., & Schofield, P. R. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.09.014 · Cited by 279
Barnett, J. H., Jones, P. B., Robbins, T. W., & Müller, U. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001973 · Cited by 274
Subtyping schizophrenia: implications for genetic research
Jablensky, A. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001857 · Cited by 268
Tan, H.-Y., Callicott, J. H., & Weinberger, D. R. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm069 · Cited by 266
Fan, J.-B., Zhang, C.-S., Gu, N.-F., Li, X.-W., Sun, W.-W., Wang, H.-Y., Feng, G.-Y., St. Clair, D., & He, L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.018 · Cited by 259
Munafò, M. R., Bowes, L., Clark, T. G., & Flint, J. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001664 · Cited by 259
Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Gray, J. A., & Roth, B. L. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm074 · Cited by 225
COMT Polymorphisms and Anxiety-Related Personality Traits
Stein, M. B., Fallin, M. D., Schork, N. J., & Gelernter, J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300787 · Cited by 224
“It has been extensively studied as a candidate gene for schizophrenia, with some replicated evidence of the involvement of the val/ met (rs4680) variant in the etiology of this syndrome (Glatt et al, 2003).”
BackgroundCraddock, N., Owen, M. J., & O'Donovan, M. C. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001808 · Cited by 216
Molecular genetic studies of schizophrenia
Riley, B., & Kendler, K. S. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201571 · Cited by 190
Is COMT a Susceptibility Gene for Schizophrenia?
Williams, H. J., Owen, M. J., & O'Donovan, M. C. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm019 · Cited by 177
Nohesara, S., Ghadirivasfi, M., Mostafavi, S., Eskandari, M.-R., Ahmadkhaniha, H., Thiagalingam, S., & Abdolmaleky, H. M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.06.013 · Cited by 168
Stefanis, N. C., Os, J. V., Avramopoulos, D., Smyrnis, N., Evdokimidis, I., Hantoumi, I., & Stefanis, C. N. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.038 · Cited by 138
Barnett, J. H., Heron, J., Ring, S. M., Golding, J., Goldman, D., Xu, K., & Jones, P. B. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.142 · Cited by 134
Dempster, E. L., Mill, J., Craig, I. W., & Collier, D. A. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-10 · Cited by 129
“A recent meta-analysis of the common val158met polymorphism and schizophrenia failed to find overall evidence for a significant association [ 17 ,18].”
Hains, A. B., & Arnsten, A. F. T. (2008) · Learning & Memory · doi:10.1101/lm.921708 · Cited by 127
“Indeed, there is evidence that the COMT valine variation is a weak risk factor for schizophrenia (Egan et al. 2001; Glatt et al. 2003), although such studies have produced mixed results (e.”
ResultMurphy, B. C., O'Reilly, R. L., & Singh, S. M. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30134 · Cited by 102
“The results append a novel dimension to the role and functioning of the COMT gene, which remains a strong candidate in the causation/predisposition for SZ [Glatt et al., 2003; Chen et al., 2004].”
BackgroundFurther evidence for high rates of schizophrenia in 22q11.2 deletion syndrome
Monks, S., Niarchou, M., Davies, A. R., Walters, J. T. R., Williams, N., Owen, M. J., van den Bree, M. B. M., & Murphy, K. C. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.020 · Cited by 93
Review: HPA‐axis activity in alcoholism: examples for a gene–environment interaction
Clarke, T., Treutlein, J., Zimmermann, U. S., Kiefer, F., Skowronek, M. H., Rietschel, M., Mann, K., & Schumann, G. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00084.x · Cited by 80
Wahlstrom, D., White, T., Hooper, C. J., Vrshek-Schallhorn, S., Oetting, W. S., Brott, M. J., & Luciana, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.045 · Cited by 66
Michaelovsky, E., Gothelf, D., Korostishevsky, M., Frisch, A., Burg, M., Carmel, M., Steinberg, T., Inbar, D., Apter, A., & Weizman, A. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008085 · Cited by 53
Cognitive impairment as a risk factor for psychosis
Reichenberg, A. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.1/areichenberg · Cited by 49
Depressive symptoms in schizophrenia and dopamine and serotonin gene polymorphisms
Peitl, V., Štefanović, M., & Karlović, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.011 · Cited by 48
“Statistical significance at the threshold of p≤ 0.05. et al., 2010; Lee et al., 2009) and COMT (Glatt et al., 2003; Sazci et al., 2004; Voisey et al., 2012; Wonodi et al., 2003).”
InfluentialEffects of Comt Genotype on Behavioral Symptomatology in the 22q11.2 Deletion Syndrome
Bearden, C. E., Jawad, A. F., Lynch, D. R., Monterossso, J. R., Sokol, S., McDonald-McGinn, D. M., Saitta, S. C., Harris, S. E., Moss, E., Wang, P. P., et al. (2005) · Child Neuropsychology · doi:10.1080/09297040590911239 · Cited by 42
Metadata
- Authors
- Glatt, S. J., Faraone, S. V., & Tsuang, M. T.
- Venue
- American Journal of Psychiatry
- Published
- 2003-03-01
- Volume
- 160
- Issue
- 3
- Pages
- 469-476
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2131871863
- Cited by
- 344
- References
- 42
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.